Get started
Work

The Diagnostic Trap: When PSA Results Mislead – A Case Report

Year: 2025
Type: article
Study design: Case Report
Abstract: Introduction: Immunoassays used in clinical practice can occasionally yield falsely elevated or suppressed results due to assay interference. We present a patient case of metastatic prostate cancer where plasma prostate-specific antigen (PSA) concentrations were falsely low. This was discovered incidentally, when a different laboratory, using another PSA assay, reported significantly higher values. Case Presentation: A 77-year-old man, diagnosed with prostate adenocarcinoma in 2011, developed bone metastases in 2015 and metastatic castration-resistant prostate cancer (mCRPC) in 2016. Between 2016 and 2017, PSA measurements at a different hospital using the Roche Cobas e602 assay, showed significantly higher plasma PSA concentrations compared to those measured at the initial hospital, using the Abbott Architect assay. Due to this discrepancy, which was inconsistent with the patient's clinical status, the clinician contacted the laboratory. Subsequent investigation revealed an assay interference leading to falsely low PSA results with the Abbott Architect Assay. Conclusion: This case underscores the importance of close collaboration between clinicians and laboratories, as well as the need to consider analytical interference when clinical findings do not match laboratory results. Laboratories must continue working with assay manufacturers to minimize interference risks, and clinicians should remain vigilant for potential diagnostic pitfalls and consult the laboratory when inconsistencies arise.
DOI: 10.1159/000543661
Authors: Johan Baden Birk-Korch, Christine Vestergaard Madsen, Tobias Kromann-Tofting, Jonas Ellegaard Mortensen, Jonna Skov Madsen, Patricia Diana Soerensen
Language: English
Subfield: Physiology
Field: Medicine
Open Access status: gold
Estimated APC paid: $1,170
OpenAlex ID: W4407158558
FWCI:
Cites: 12
Cited by:
Related to: 10